Connect with us

Coronavirus

195 new cases of COVID-19 recorded in Nigeria

On the 21st of September 2020, 195 new confirmed cases and 2 deaths were recorded in Nigeria.

Published

on

195 fresh cases of COVID-19 were recorded in Nigeria on Monday, September 21.

According to statistics released by the Nigeria Centre for Disease Control (NCDC), Lagos reported 39 cases while the FCT recorded 15 fresh cases.

Other states with new cases include Enugu – 51, Gombe – 40, Plateau – 23, Rivers – 12, Kaduna –8, Ondo – 3, Bauchi – 2, Edo and Ogun each reporting 1 case.

48,674 patients have been effectively treated and discharged since the initial outbreak of the virus on February 27 2020. 1,100 deaths have so far been recorded.

See breakdown of the number of cases per states below

Advertisement
Click to comment

Leave a Reply

Coronavirus

US Tennis player Sam Querrey accused of fleeing Russia on private jet after testing positive for COVID-19

Published

on

33 year old US tennis player Sam Querrey, has been accused of fleeing Russia on a private jet after he and his family tested positive for Covid-19.

Querrey and his wife had tested positive for the virus ahead of the St. Petersburg Open this week and were placed in quarantine at a  hotel, according to the tournament organizers.

Doctors had recommended Querrey and his family be moved to a private apartment but he did not allegedly answer the door when doctors were dispatched to evaluate his condition.

“Sam Querrey was scheduled to retest on Thursday, October 15, however, instead of acting in accordance with ATP rules and the tournament’s sanitary protocol, Sam Querrey was recorded leaving the hotel by hotel security cameras at 5.45 a.m. on October 13, with his family, without notifying the reception,”

“As Querrey told the ATP representative, he and his family left Russia on a private plane.” read a statement from organizers.

The ATP which is the World tennis controlling body, said it was aware of an incident “regarding a player’s serious breach of protocol”

Querrey has not won a grand slam singles title in his career but is ranked world number 47.

Querrey has not responded to the allegations as at press time.

Continue Reading

Coronavirus

WHO study reveals new discovery about remdesivir drug’s effect on Covid-19 patients

The study found that the regimens appeared to have little or no effect on 28-day mortality or the length of the in-hospital course.

Published

on

A World Health Organization (WHO) study has discovered that Gilead Sciences Inc’s remdesivir had little or no effect on COVID-19 patients’ length of stay in the hospital or chances of survival.

The only antiviral drug authorized for treatments of Covid-19 in the US failed to prevent deaths among patients.

The antiviral medication, among the first to be used as a treatment for COVID-19, was one of the drugs recently used to treat U.S. President Donald Trump’s coronavirus infection.

The results are from WHO’s Solidarity trial, which evaluated the effects of 4 potential drug regimens, including remdesivir, hydroxychloroquine, anti-HIV drug combination lopinavir/ritonavir and interferon, in 11,266 adult patients across more than 30 countries.

The study found that the regimens appeared to have little or no effect on 28-day mortality or the length of the in-hospital course among patients hospitalized with COVID-19, the WHO said on Thursday.

The results of the trial, which were posted online on Thursday, October 15, 2020, are yet to be peer-reviewed or published in a scientific journal

Earlier this month, data from a U.S. study of remdesivir by Gilead showed that the treatment cut COVID-19 recovery time by five days compared with patients who got a placebo in a trial comprising 1,062 patients.

Gilead told Reuters, “The emerging (WHO) data appears inconsistent, with more robust evidence from multiple randomized, controlled studies published in peer-reviewed journals validating the clinical benefit of remdesivir.

“We are concerned the data from this open-label global trial has not undergone the rigorous review required to allow for constructive scientific discussion, particularly given the limitations of the trial design.”

Remdesivir, which was originally developed as a treatment for Ebola and Hepatitis C, interferes with the reproduction of viruses by jamming itself into new viral genes.

WHO chief scientist Soumya Swaminathan said on Wednesday that during the study, hydroxychloroquine and lopinavir/ritonavir were stopped in June after they proved ineffective, but other trials continued in more than 500 hospitals and 30 countries.

Swaminathan said, “We’re looking at what’s next. We’re looking at monoclonal anti-bodies, we’re looking at immunomodulators and some of the newer anti-viral drugs that have been developed in the last few months.”

Remdesivir received emergency use authorization from the U.S. Food and Drug Administration on May 1, and has since been authorized for use in several countries.

Gilead, however, disputed the conclusions of the W.H.O. study on Thursday, noting that a variety of drugs and drug combinations had been evaluated under a wide range of circumstances and that more rigorous studies had found a benefit.

Continue Reading

Coronavirus

148 new cases of Coronavirus recorded in Nigeria

On the 15th of October 2020, 148 new confirmed cases were recorded in Nigeria

Published

on

148 new cases of Coronavirus were recorded in Nigerian on Thursday October 15, as confirmed by the Nigeria Centre for Disease Control (NCDC).

A breakdown of the new cases is as follows; Lagos (66), FCT (25), Oyo (13), Plateau (11), Kaduna (7), Rivers (6), Ebonyi (5), Ekiti (4), Ogun (4), Imo (2), Ondo (2), Edo (1), Nasarawa (1), Taraba (1).

A total of 60,982 cases have been confirmed in the country, 52,194 cases have been discharged and 1,116 deaths have been recorded in 36 states and the Federal Capital Territory.

Continue Reading
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement

Follow us on Twitter

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 87 other subscribers

Trending